Urology News and Research

Latest Urology News and Research

Watson, GeneraMedix receive FDA approval for Nulecit to treat iron deficiency anemia

Watson Pharmaceuticals, Inc. today announced that it is initiating launch activities of Nulecit, following FDA approval of GeneraMedix Inc.'s, Abbreviated New Drug Application.

1 Apr 2011

Mitomics introduces new test to detect prostate cancer

Mitomics, world leader in the research and development of mitochondrial genome-based products to improve clinical insight and therapeutic decisions, announced today the launch of its flagship product, the Prostate Core Mitomic Test, a revolutionary new test that uses the science of mitochondrial DNA to accurately determine the absence or presence of cancerous cells using previously obtained prostate biopsy tissue.

1 Apr 2011

Protox reports net loss of $4.5 million for year ended December 31, 2010

Protox Therapeutics Inc., a leader in the development of receptor targeted therapeutic fusion proteins, today announced financial results and achievements for the year ended December 31, 2010.

31 Mar 2011

Regular CT scans can cause secondary malignancies in older men with testicular cancer

UC Davis cancer researchers have found that older men with early-stage testicular cancer who opt for surveillance with regular CT scans over lymph node removal are at greater risk for secondary cancers.

31 Mar 2011

Study provides insight into kidney cancer

Researchers at UT Southwestern Medical Center have discovered genetic pathways to starve selectively kidney cancer cells.

31 Mar 2011

XTRAC laser therapy can offer relief to patients with severe psoriasis

PhotoMedex, Inc. announced today the implications of the preliminary findings of a current clinical trial being performed by John Y.M. Koo, M.D., professor and vice chairman, department of dermatology, University of California, San Francisco. Dr. Koo's experimental treatment protocol could change the lives of millions of people suffering from moderate to severe psoriasis.

30 Mar 2011

UT Southwestern Medical Center tops best hospital rankings for Dallas-Fort Worth

UT Southwestern Medical Center ranked as the best hospital in Dallas-Fort Worth in the newly expanded U.S. News & World Report's America's Best Hospitals rankings for 52 metropolitan areas.

30 Mar 2011

Alpha II, PCIS Gold enter integration contract

Alpha II, a leader in healthcare coding, compliance and reimbursement, announced today a new integration contract with PCIS Gold, a provider of single-source medical group practice software. Alpha II's ClaimStaker software will enhance coding reliability, while increasing professional and institutional claim validity for PCIS Gold's customers.

28 Mar 2011

U.S. District Court rules in favor of Watson in generic SEASONIQUE patent infringement suit

Watson Pharmaceuticals, Inc., a leading integrated global pharmaceutical company, today confirmed that it has received a favorable decision from the U.S. Court of Appeals for the Federal Circuit related to its ongoing patent challenge in connection with Watson's Abbreviated New Drug Application seeking FDA approval to market a generic version of Teva Women's Health, Inc.'s SEASONIQUE and ethinyl estradiol.

28 Mar 2011

US District Court rules against Watson in generic Fentora patent suit

Watson Pharmaceuticals, Inc., today confirmed that the United States District Court for the District of Delaware has ruled that Watson's generic version of Fentora® (fentanyl buccal tablets C-II) infringes United States Patent No. 6,264,981 (the '981 Patent). The Company said that it was reviewing the court's decision and would evaluate all available options, including an appeal.

25 Mar 2011

AltheRx purchases all assets related to Solabegron from GlaxoSmithKline

AltheRx Inc., a privately-held clinical development company, announced today that it has purchased all assets related to Solabegron from GlaxoSmithKline. Solabegron is a highly selective and potent beta3-adrenoceptor agonist that has demonstrated positive results in Phase II clinical programs for the treatment of Overactive Bladder in women and Irritable Bowel Syndrome.

25 Mar 2011

Mouse sperm created in lab: Hope for male infertility

In a scientific breakthrough, researchers report that they've grown mouse sperm from testicular tissue in the laboratory, a development that could advance the field of infertility in human males. Although still proven in mice, “this is a small but important step in understanding how sperm are formed, which may, in time, lead to us being able to grow human sperm in the laboratory,” said Dr. Allan Pacey, senior lecturer in andrology at the University of Sheffield in England, who is familiar with the study results.

24 Mar 2011

Robotic surgery for prostate cancer safe over the long term

In the first study of its kind, urologists and biostatisticians at Henry Ford Hospital have found that robot-assisted surgery to remove cancerous prostate glands is safe over the long term, with a major complication rate of less than one percent.

24 Mar 2011

New study: Prostate and breast cancer usually recur in bone

Like bad neighbors who decide to go wreck another community, prostate and breast cancer usually recur in the bone, according to a new University of Michigan study.

24 Mar 2011

NeoTract initiates patient enrollment for UroLift System trial to treat prostrate cancer

NeoTract, Inc. a medical device company focused on developing urology devices, today announced that the first U.S. patients have been enrolled in a multinational trial of its UroLift® System at Western Urological Clinic in Salt Lake City, Utah.

23 Mar 2011

Astellas announces positive results from mirabegron phase III trials against OAB

Astellas Pharma Inc. today announced the results of two pivotal phase III clinical trials for mirabegron, the first of a new class of compounds under development for the treatment of overactive bladder, show mirabegron significantly improves key OAB symptoms - urinary incontinence and frequency of micturition.

23 Mar 2011

Positive results from TheraVida THVD-201 Phase 1 trial in patients with OAB, UUI

TheraVida, Inc., a clinical stage biopharmaceutical company developing novel combination drug products, today presented positive results from a Phase 1 clinical trial of its lead product candidate THVD-201 for the treatment of overactive bladder and urge urinary incontinence.

23 Mar 2011

City Of Hope opens new center for diabetes research and care

City of Hope has established a new Diabetes Research Center that will expand its pioneering investigations into diabetes, endocrinology and metabolic diseases, create an infrastructure to support translational research and enhance clinical care for diabetes and its related complications.

22 Mar 2011

Watson introduces Famciclovir tablets to treat cold sores, genital herpes

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. has launched Famciclovir tablets, 125 mg, 250 mg and 500 mg, the generic version of Novartis' Famvir following approval of its Abbreviated New Drug Application by the U.S. Food and Drug Administration.

22 Mar 2011

The Lancet publishes Oceana's Solesta injectable gel study results against fecal incontinence

Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced the publication of results from a randomized-controlled clinical trial of the bulking agent, NASHA DX, a dextranomer suspended in stabilized, which was injected into the submucosa of the anal canal in patients with fecal incontinence.

19 Mar 2011

Urology News and Research

Latest Urology News and Research

Watson, GeneraMedix receive FDA approval for Nulecit to treat iron deficiency anemia

Mitomics introduces new test to detect prostate cancer

Protox reports net loss of $4.5 million for year ended December 31, 2010

Regular CT scans can cause secondary malignancies in older men with testicular cancer

Study provides insight into kidney cancer

XTRAC laser therapy can offer relief to patients with severe psoriasis

UT Southwestern Medical Center tops best hospital rankings for Dallas-Fort Worth

Alpha II, PCIS Gold enter integration contract

U.S. District Court rules in favor of Watson in generic SEASONIQUE patent infringement suit

US District Court rules against Watson in generic Fentora patent suit

AltheRx purchases all assets related to Solabegron from GlaxoSmithKline

Mouse sperm created in lab: Hope for male infertility

Robotic surgery for prostate cancer safe over the long term

New study: Prostate and breast cancer usually recur in bone

NeoTract initiates patient enrollment for UroLift System trial to treat prostrate cancer

Astellas announces positive results from mirabegron phase III trials against OAB

Positive results from TheraVida THVD-201 Phase 1 trial in patients with OAB, UUI

City Of Hope opens new center for diabetes research and care

Watson introduces Famciclovir tablets to treat cold sores, genital herpes

The Lancet publishes Oceana's Solesta injectable gel study results against fecal incontinence

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Urology News and Research

Latest Urology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in